07/17/2025
7:40 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2025
4:06 PM | Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
4:05 PM | Legorreta Pablo G. (Filed by)
Royalty Pharma (Subject)
| Form SCHEDULE 13D | |
05/20/2025
3:49 PM | Legorreta Pablo G. (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
3:51 PM | Lloyd George W. (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
3:52 PM | Coyne Terrance P. (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:22 PM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
4:41 PM | Engelbert Catherine M. (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
4:04 PM | Bassler Bonnie L (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
4:06 PM | Coric Vlad (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
4:07 PM | DESOUZA ERROL B (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for RPRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Royalty Pharma and its competitors with MarketBeat's FREE daily newsletter. |
05/14/2025
4:08 PM | Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
4:09 PM | HODGSON DAVID C (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
4:11 PM | LOVE TED W (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
4:12 PM | Norden Gregory (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2025
9:39 AM | Royalty Pharma (Subject)
| Form SCHEDULE 13G/A | |
05/09/2025
4:07 PM | Royalty Pharma (Issuer)
Urist Marshall (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:10 PM | Coyne Terrance P. (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:14 PM | Hite Christopher (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:15 PM | Lloyd George W. (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:18 PM | Legorreta Pablo G. (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
8:14 AM | Royalty Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2025
6:31 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2025
5:19 PM | Royalty Pharma (Subject)
Severgnini Achille G. (Filed by)
| Form SCHEDULE 13D/A | |
04/21/2025
4:43 PM | Coric Vlad (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:40 PM | Coric Vlad (Reporting)
Royalty Pharma (Issuer)
| Form 3/A | |
04/21/2025
4:18 PM | Royalty Pharma (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/11/2025
8:15 AM | Royalty Pharma (Filer)
| Form DEFA14A | |
04/11/2025
7:45 AM | Royalty Pharma (Filer)
| Form DEFM14A | |
04/11/2025
7:50 AM | Royalty Pharma (Filer)
| Form ARS | |
04/11/2025
7:53 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2025
3:17 PM | Royalty Pharma (Filer)
| Form DEFA14A | |
04/10/2025
3:06 PM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2025
4:45 PM | Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
4:46 PM | Bassler Bonnie L (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
4:25 PM | Royalty Pharma (Filer)
| Form DEFA14A | |
02/21/2025
3:30 PM | Royalty Pharma (Subject)
Severgnini Achille G. (Filed by)
| Form SCHEDULE 13D/A | |
02/13/2025
5:03 AM | Royalty Pharma (Filer)
| Form PREM14A | |
02/12/2025
8:30 AM | FMR LLC (Filed by)
Royalty Pharma (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
6:38 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2025
4:12 PM | Royalty Pharma (Filer)
| Form DEFA14A | |
A grave, grave error. (Ad) Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history.
But one analyst who predicted the collapse of Fannie Mae and GM says the AI giant is now headed for a brutal crash… and it could hit as soon as this year. Watch his urgent Nvidia exposé before it’s too late |
01/16/2025
4:15 PM | Royalty Pharma (Filer)
| Form DEFA14A | |
01/15/2025
4:04 PM | Royalty Pharma (Subject)
| Form 425 | |
01/13/2025
7:40 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
7:42 AM | Royalty Pharma (Filer)
| Form DEFA14A | |
01/10/2025
4:21 PM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
4:26 PM | Royalty Pharma (Filer)
| Form DEFA14A | |
01/10/2025
6:47 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/31/2024
3:05 PM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
2:15 PM | MORGAN STANLEY (Filed by)
Royalty Pharma (Subject)
| Form SC 13G/A | |
11/06/2024
8:24 AM | Royalty Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
6:35 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
4:07 PM | Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:08 PM | Bassler Bonnie L (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
7:39 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
6:17 PM | Royalty Pharma (Issuer)
Urist Marshall (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
6:19 PM | Lloyd George W. (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
6:20 PM | Coyne Terrance P. (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
8:02 AM | Royalty Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
6:20 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
6:04 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
3:30 PM | Royalty Pharma (Subject)
Severgnini Achille G. (Filed by)
| Form SC 13D/A | |
